Cargando…
Arginine metabolism: a potential target in pancreatic cancer therapy
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an extremely low survival rate of <9% in the United States. As a new hallmark of cancer, metabolism reprogramming exerts crucial impacts on PDAC development and progression. Notably, arginine metabolism is altere...
Autores principales: | Yang, Jin-Shou, Wang, Cheng-Cheng, Qiu, Jiang-Dong, Ren, Bo, You, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862822/ https://www.ncbi.nlm.nih.gov/pubmed/33395072 http://dx.doi.org/10.1097/CM9.0000000000001216 |
Ejemplares similares
-
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer
por: Hsu, Ming-Chuan, et al.
Publicado: (2019) -
Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy
por: Xiong, Lifeng, et al.
Publicado: (2016) -
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
por: Qin, Cheng, et al.
Publicado: (2020) -
Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment
por: Hou, Xiaoshuang, et al.
Publicado: (2022) -
Targeting the arginine metabolic brake enhances immunotherapy for leukaemia
por: Mussai, Francis, et al.
Publicado: (2019)